The chemical class known as RNF135 Activators comprises a diverse array of compounds that, while not directly interacting with RNF135, a protein involved in immune response and inflammation regulation, are theorized to modulate its activity through various indirect pathways. This class includes molecules that activate signaling pathways known to intersect with the functional landscape of RNF135. For instance, compounds like Lipopolysaccharides (LPS) are recognized for their ability to stimulate the immune system, potentially enhancing RNF135 activity by activating NF-kB signaling, a pathway integral to immune and inflammatory responses. Other members of this class, such as Phorbol 12-Myristate 13-Acetate (PMA) and Forskolin, act through the activation of Protein Kinase C (PKC) and the increase of cAMP levels, respectively, pathways that can have cascading effects on cellular signaling networks involving RNF135.
Furthermore, this class encompasses agents like Ionomycin, which elevates intracellular calcium levels, potentially affecting RNF135 through calcium-dependent signaling pathways. The inclusion of compounds like Isoproterenol, a beta-adrenergic agonist, reflects the broad scope of indirect influences on RNF135, considering the interconnected nature of cellular signaling networks. Anisomycin, known for its ability to stimulate stress response pathways like JNK and p38 MAPK, might also impact RNF135 activity. Poly(I:C), a synthetic analog of double-stranded RNA, highlights the role of immune response simulation in the potential modulation of RNF135. Additionally, natural compounds like Resveratrol are part of this class, considering their multifaceted role in modulating various signaling pathways. This diverse chemical class, therefore, represents a spectrum of molecules that, through their engagement with different cellular pathways and processes, offer potential routes to indirectly influence the activity of RNF135. The underlying concept uniting these compounds is their capacity to alter the cellular milieu in ways that can modulate the activity of proteins involved in immune and inflammatory responses, showcasing the complexity and interconnectivity of cellular signaling.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
As stimulators of the immune response, LPS can activate NF-kB pathways, potentially influencing RNF135 activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates Protein Kinase C (PKC), which can influence RNF135 activity through downstream signaling effects. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases cAMP levels, potentially enhancing RNF135 activity through cAMP-dependent signaling pathways. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Increases intracellular calcium, potentially affecting RNF135 activity through calcium-dependent signaling pathways. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
A beta-adrenergic agonist that might influence RNF135 through adrenergic signaling pathways. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Stimulates JNK and p38 MAPK pathways, potentially affecting RNF135 activity in stress response. | ||||||
Polyinosinic-polycytidylic acid potassium salt | 31852-29-6 | sc-202767 | 5 mg | $198.00 | ||
A synthetic analog of double-stranded RNA, may enhance RNF135 activity through immune response pathways. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Can modulate various signaling pathways, potentially affecting RNF135 activity in immune and inflammatory responses. | ||||||